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Background: We previously identified CK1α as a novel tumor suppressor in melanoma and reported that the loss
of CK1α leads to increased proliferation and invasive growth of melanoma cells by strong activation of the Wnt/β-
catenin signaling pathway.
Methods: In this study we analyzed expression and the functional effects of the dominantly expressed CK1- isoforms α,
δ and ε in melanoma cells by quantitative real-time PCR, western blot and immunohistochemistry. We down-regulated
CK1 kinase activity with isoform specific siRNAs and small molecule inhibitors. Vice versa we overexpressed the CK1
isoforms α, δ and ε using viral vectors and tested the biological effects on melanoma cell proliferation, migration and
invasion.
Results: We show that protein expression of all three CK1-isoforms is downregulated in metastatic melanoma cells
compared to benign melanocytic cells. Furthermore, the CK1δ and ε isoforms are able to negatively regulate expression
of each other, whereas CK1α expression is independently regulated in melanoma cells. Inhibition of the expression and
activity of CK1δ or CK1ε by specific inhibitors or siRNAs had no significant effect on the growth and survival of
metastatic melanoma cells. Moreover, the over-expression of CK1δ or CK1ε in melanoma cells failed to induce cell death
and cell cycle arrest although p53 signaling was activated. This is in contrast to the effects of CK1α where up-regulated
expression induces cell death and apoptosis in metastatic melanoma cells.
Conclusion: These data indicate that CK1α has a dominant and non-redundant function in melanoma cells and that the
CK1δ and ε isoforms are not substantially involved in melanoma progression.
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Malignant melanoma is the most aggressive form of skin
cancer whose incidence still increases worldwide. Mela-
nomas arise from the transformation of benign melano-
cytes or nevi which can develop into dysplastic lesions
before progressing into primary melanomas that can fur-
ther invade into the dermis and metastasize via
hematogenous or lymphogenic routes to distant sites [1].
Initiation and progression of melanoma have been asso-
ciated with activation of key signaling pathways involved
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signaling pathways as well as the Wnt/beta-catenin sig-
naling pathway [2].
Protein kinases play a central role in signal transduction.
By reversible phosphorylation of its substrate proteins,
they exert influence on their activity, localization and
function and thus are involved in almost all cellular pro-
cesses and functions. The casein kinases (CK) belong to
the serine/threonine kinases that are involved in a variety
of cellular processes. Isoforms of the casein kinase 1
(CK1) family have been shown to phosphorylate key regu-
latory molecules involved in cell cycle, transcription and
translation, the structure of the cytoskeleton, cell-cell ad-
hesion and in receptor-coupled signal transduction. CK1
isoforms are key regulators of several cellular growth andle is distributed under the terms of the Creative Commons Attribution 4.0
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naling, cell cycle control, DNA repair and apoptosis [3, 4].
In humans, six CK1 isoforms exist (α, γ1, γ2, γ3, δ and
ε) and several splice variants for CK1α, δ, ε and γ3 have
been identified. All CK1 isoforms possess a highly con-
served kinase domain, but differ in length and sequence
of the N-terminal and especially the C-terminal non-
catalytic domains. CK1α plays a role in the mitotic spin-
dle formation during cell division and in DNA repair
mechanisms and further participates in RNA metabolism
[3, 4]. The CK1 isoforms δ and ε are known to be im-
portant regulators in the circadian rhythm of eukaryotic
cells. CK1α regulates apoptotic signaling pathways, how-
ever, there seem to be cell type-specific differences. In
addition to the involvement in apoptotic signaling path-
ways, the CK1 isoforms α, δ and ε have important regu-
latory functions in the Wnt/β-catenin signaling pathway
and seems to act in a concerted manner [5, 6]. Dishev-
elled (Dvl) is a key component in the Wnt/β-catenin sig-
naling pathway. Upon pathway activation by Wnts, Dvl
becomes phosphorylated by CK1 δ/ε [7]. CK1α acts as a
negative regulator of the the Wnt/β-catenin signaling
pathway by acting as a priming kinase for β-catenin
phosphorylation on Ser45 which is a pre-requisite for
further phosphorylations by GSK3β at the Ser/Thr resi-
dues 33, 37 and 41 [6, 8]. Without this priming phos-
phorylation β-catenin is not degraded and gets
stabilized. A down-regulation of CK1α thus leads - due
to the lack of “priming” phosphorylation - to an accu-
mulation of cytoplasmic β-catenin. Indeed, we could
show in metastatic melanoma cells that CK1α is down-
regulated which correlated with increased β-catenin
stability [9].
The tumor suppressor protein p53 as well as the p53
interacting proteins MDM2 and MDMX are substrates of
the three CK1 isoforms CK1α, CK1δ and CK1ε. In differ-
ent cell systems CK1α and CK1δ are described to regulate
p53 activity by phosphorylation of p53 itself or the p53
interacting proteins MDM2 and MDMX [3, 4, 10, 11].
Furthermore, the activity of p53 correlates with CK1α and
CK1δ expression under stress conditions which points to
an autoregulatory loop between CK1 isoforms and p53
[10, 11].
Some evidence points to an altered expression or ac-
tivity of different CK1 isoforms in tumor cells. Database
analyses from tumor cell lines and tissues indicated that
the CK1δ and CK1ε isoforms might be slightly overex-
pressed on RNA level in some tumor types including
melanoma, whereas RNA expression of CK1α is more
variable but low in melanoma [4]. The CK1γ1-3 iso-
forms seem to be rather low in different cancers types.
Expression analysis of CK1α in melanoma datasets
clearly revealed a reduction in mRNA expression during
melanoma progression and we could confirm thereduction of CK1α expression in metastatic melanoma
cells on RNA and protein level [4, 9]. However, expres-
sion of the other CK1 isoforms has not been systematic-
ally analyzed in melanoma cells until now. Furthermore,
it is not known whether there is a functional redundancy
of the CK1 isoforms in the regulation of cell survival
and tumorigenesis since several substrates are shared
within the CK1 family such as β-catenin in the canonical
Wnt pathway and p53 or Mdm-2 in the p53 signaling
pathway [3, 4].
To identify the role of the different CK1 isoforms dur-
ing melanoma progression we analyzed in this study a)
the expression of the CK1 isoforms in melanoma cells of
different progression stages in vitro and in vivo, b) the
reciprocal influence of CK1 isoform expression for the
α, δ and ε family members and c) the functional effects
of gene expression modulation of individual CK1-
isoforms (alpha, delta and epsilon) on melanoma cell
survival, proliferation, migration and invasion.
Methods
Cell culture
Human melanoma cell lines were cultured for this study
in RPMI 1640 medium with 2 mM L-Glutamine and
10 % fetal bovine serum (FBS; Biochrom, Berlin,
Germany), penicillin, and streptomycin. They were sub-
cultured 1–2 times a week when they reached 80 % con-
fluency using Trypsin/EDTA (0.05 %/0.02 %) for
detachment [9, 12]. The melanoma cell lines Malme-
3 M, MDAMB435, M14, UACC62, SKMel28 and A375
originated from the NCI60 cell panel of the National
Cancer Institute (NCI-DCTD repository). The melan-
oma cell lines WM35, WM115, WM793, WM3734,
WM266-4, WM1366, 1205 LU, and 451 LU were gener-
ously provided by M. Herlyn (Philadelphia, USA). SbCl2
and SKMel19 were provided by C. Garbe (Tübingen,
Germany). SKMEL30 was obtained from the DSMZ
(Braunschweig, Germany) and SKMel147 was a kind gift
of M. Soengas (Madrid, Spain). Melanocytes, primary fi-
broblasts and keratinocytes were isolated from human
foreskin as described previously [13–15]. All of the cell
lines used in our study were authenticated by sequence
analysis of defined genes.
siRNA mediated CK1 knockdown
2.5 × 105 melanoma cells in 6well cavities were transfected
with 50 pmol siRNA using RNAiMAX (Invitrogen, Darm-
stadt, Germany) according to the manufacturers protocol.
The following siRNAs were used: siCSNK1A1 sense
gaauuugcgauguacuuaa-dTdT, siCSNK1A1 antisense uuaa
guacaucgcaaauuc-dTdG; siCSNK1D sense ugaucagucgca
ucgaaua-dTdT, siCSNK1D antisense uauucgaugcgac
ugauca-dTdT; siCSNK1E sense ccuccgaauucucaacaua-
dTdT, siCSNK1E antisense uauguugagaauucggagg-dGdA;
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antisense gggggcagcuauaugaauguugu (all synthesized by
biomers.net, Ulm, Germany)
Overexpression of CK1α/ δ/ ε
Wild type CK1 isoform cDNA was amplified using the
Human Multiple Tissue cDNA (MTC) Panel II (Clon-
tech, Saint-Germain-en-Laye, France) and isoform spe-
cific primers. CK1 cDNAs were cloned into the
inducible lentiviral vector PLVX-tight-PURO (Clontech)
by using In-fusion-HD Liquid Kits (Clontech) according
to the manufacturer’s protocol. Sanger-sequencing was
performed for verification of the correct cloned cDNA.
Lentiviral particles were produced in HEK293T cells
using the second-generation packing and envelope plas-
mids pCMVΔR8.2 and pMD2.G. Cells were transduced
with lentiviruses as described previously [16] and doxy-
cycline inducible melanoma cells were generated accord-
ing to the manufacturer’s instructions (Tet-on Advanced
System, Clontech). For overexpression of CK1α the pre-
viously described adenovirus was used [9].
Inhibitor and doxycycline treatments
Small molecules were dissolved in DMSO and treat-
ments were carried out using the indicated concentra-
tions with vehicle controls. The following substances
were used: Pyrvinium pamoate (Sigma, Taufkirchen,
Germany), IC261 (Sigma), D4476 (Sigma), PF670462
(Sigma). Doxycycline hyclate (Applichem, Darmstadt,
Germany) was dissolved in ddH2O and used at the indi-
cated concentrations.
4-Methylumbelliferyl heptanoate (MUH) viability assay
For the analysis of proliferation and survival of mel-
anoma cells, 2.5x103 cells were seeded into 96-well
plates and cultured with the indicated inhibitors for
the indicated periods of time. After washing of the
cells with PBS, 100 μg/ml 4-methylumbelliferyl hep-
tanoate (Sigma, Taufkirchen, Germany) in PBS were
added and incubated for 1 h at 37 °C. Microplates
were measured in a fluorescence microplate reader
(Berthold, Bad Wildbad, Germany) with Ex355/Em460
nm in sixtuplicates. Dose–response curves were gen-
erated using GraphPad Prism version 6 (GraphPad
Prism Software Inc.).
Cell cycle assay
2 x105 melanoma cells per 6-well cavity were seeded and
either transfected using siRNA or treated with 4 μg/ ml
doxycycline to induce the overexpression of CK1δ and ε
or transduced with the adenovirus (CK1α overexpres-
sion). Cells were cultured for 48 h before
permeabilization and fixation of the cells in 70 % ice-
cold ethanol for at least 1 h. Then they were re-suspended in PBS with 100 μg/ml RNAseA (Applichem,
Darmstadt, Germany) and 50 μg/ml propidium iodide
(Sigma, Taufkirchen, Germany) and stained for 30 min.
FACS analysis for the detection of the distribution of the
cells in the each cell cycle phase was performed with a
LSRII FACS (BD, Heidelberg, Germany) using the
FACSDiva software.3D Melanoma spheroid culture
2.5 × 103 SKMel19 cells were cultured on 1.5 % noble agar
(Difco/BD, Heidelberg, Germany) coated 96well plates to
form spheroids within 3 days. For overexpression of CK1
isoforms either 2 μg/ml doxycycline were added on the
second day or the medium was supplemented with the
adenovirus. After 3 days spheroids were embedded into
1 mg/ml collagen I (Corning/BD, Heidelberg, Germany)
diluted in complete growth medium and cultured for four
more days. In case of treatment inhibitors were added to
the medium. Daily microphotographs were taken and the
area of the spheroids was measured using ImageJ and nor-
malized to the size at day 0 after collagen embedding for
the evaluation of tumor cell invasion into the collagen
matrix. After 4 days spheroids were stained using 1 μM
calcein-AM (Life technologies, Darmstadt, Germany) and
100 ng/ml propidium iodide (Sigma, Taufkirchen,
Germany) for fluorescence live-dead staining of the mel-
anoma cells. Fluorescence was detected with an Axiovert
fluorescence microscope (Zeiss, Jena, Germany). Mean
fluorescence intensities of the red channel were used to
determine relative cell death induction.Quantitative PCR
Total RNA was extracted from cells using the NucleoSpin
RNA kit (Machery-Nagel, Dueren, Germany). Complemen-
tary DNA was made out of 1 μg total RNA using Super-
Script II reverse Transcriptase (Invitrogen, Darmstadt,
Germany) according to the manufacturer’s protocol. Quan-
titative real-time PCR (qRT-PCR) was performed with the
SYBR green mix LightCycler 480 (Roche, Mannheim
Germany). The relative expression levels of CK1 isoforms
were determined using the ΔΔCt-method method with
ACTINB or 18S rRNA as reference genes. The primer se-
quences were as follows: CSNK1A1 forward 5’-aatgttaaag-
cagaaagcagcac-3’ and reverse 5’-tcctcaattcatgcttagaaacc-3’.
CSNK1D forward 5’-acaacgtcatggtgatggag-3’ and reverse 5’-
gaatgtattcgatgcgactgat-3’. CSNK1E forward 5’-tgagtat-
gaggctgcacagg-3’ and reverse 5’-tcaaatggcacacttgtctgt-3’.
CSNK1G1 forward 5’-ctgtgaccgaacatttactttga-3’ and reverse
5’-tgcacgtattccattcgaga-3’. CSNK1G2 forward 5’-gacctt-
cacgctcaagacg-3’ and reverse 5’-ccggtagattaggctcttggt-3’.
CSNK1G3 forward 5’-tgcaacaatccaaaaaccagt-3’ and reverse
5’-ctgcaaggtgagctctcaaa-3’. ACTINB forward 5’-ttgttacag-
gaagtcccttgcc-3’ and reverse 5’-atgctatcacctcccctgtgtg-3’.
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5’-gctggaattaccgcggct-3’.Western blot
Protein lysates (30 μg) were subjected to SDS-PAGE and
semi-dry blotting onto PVDF membranes (Roche,
Mannheim, Germany). The antibodies used were as fol-
lows: anti-CK1α (Santa Cruz Biot., Heidelberg,
Germany), anti-CK1δ (Santa Cruz Biot.), anti-CK1ε
(Santa Cruz Biot), anti-p53 (Santa Cruz Biot), anti-p21
(Cell Signalling, Heidelberg, Germany), anti-β-catenin
(Cell Signalling), anti p-S45-β-catenin (Cell Signalling)
anti-β-actin (Cell Signalling). HRP conjugated secondary
antibodies were used (Cell Signalling and Santa Cruz)
and ECL substrates for chemoluminiscent detection.
Densitometric semi-quantification was done by normal-
izing the band intensities of the target protein to the sig-
nal of β-actin with Scion Image.Luciferase reporter assay
2.5 × 105 melanoma cells were seeded into 6well plates
and transfected with 2 μg Super8xTOPFlash 16 h porst
seeding using ScreenFectA (Genaxxon, Ulm, Germany)
as recommended by the manufacturer. Twenty-four
hours later cells were reseeded into 96 well cavities and
the expression of isoforms was induced by the addition
of doxycycline or of the adenovirus for 48 h. Then cells
were lysed with 50 μl of passive lysis buffer (Promega,
Mannheim, Germany) and luciferase activity was ana-
lyzed using D-luciferin as a substrate (Sigma) in a TriS-
tar luminometer (Berthold, Bad Wildbad, Germany).Immunofluorescence analysis of melanocytic biopsies
Nevi, primary and metastatic melanoma FFPE biopsies
were sectioned, heat induced epitope retrieval (HIER)
was performed using citrate buffer pH6 and the sections
were stained using 1:100 rabbit anti-CK1α (Abcam ab
136052), 1:1000 mouse anti-CK1δ (Abcam ab85320) and
1:100 goat anti-CK1ε (Santa Cruz sc-6471). As second-
ary antibodies donkey anti-goat(Cy3), donkey anti-
mouse(Cy2) and donkey anti-rabbit(Cy5) were used (all
1:250; JacksonImmunoResearch/Dianova, Hamburg,
Germany) before staining the nuclei with 1 μg/ml DAPI
(Sigma, Taufkirchen, Germany). Biopsies were micro-
scopically analyzed using a confocal microscope system
(Leica TCS SP2, Heidelberg, Germany) and the mean
fluorescence intensity of representative cells was quanti-
fied using the Leica LCS software. For semi-
quantification the mean fluorescent intensities of at least
30 cells per sample were background subtracted and
presented as relative fluorescence units.Kinase assay (K-LISA)
A 23mer peptide containing the exon 3 phosphorylation
sites of β-catenin was synthesized as previously
described [9] and the NH2 terminus was labeled with
biotin. Melanoma cells were lysed using passive lysis
buffer (Promega, Mannheim, Germany), and 5 μg of the
protein lysates were incubated in kinase buffer (Cell Sig-
nalling, Heidelberg, Germany) together with 10 μg of
biotin-labeled peptide for 30 min at 37 °C in
streptavidin-coated 96well plates (Life technologies,
Darmstadt, Germany). Plates were washed with PBS-T
and anti–phospho-Ser45-β-catenin antibody (Cell Sig-
naling) was added (1:500). HRP-conjugated secondary
antibody (Cell Signalling) was used to detect the phos-
phorylated substrate measuring TMB substrate (Cell Sig-
nalling) at 450 nm in a microplate reader (Berthold, Bad
Wildbad, Germany).Migration and invasion assay
Skin reconstructs
Organotypic skin reconstructs were prepared as de-
scribed previously [13, 17, 18]. SbCl2 melanoma cells
were transfected with the indicated siRNAs 24 h before
epidermal reconstruction. Ten days after air-lifting the
model reconstructs were fixed, paraffine embedded, sec-
tioned, and H&E staining revealed the invasive capacity
after knockdown of CK1α.Boyden chamber experiments
Invasion was assayed using invasion chambers coated
with or without Matrigel basement membrane matrix
(BD Biocoat Matrigel invasion chambers, BD Biosciences,
Heidelberg, Germany) as described previously [9, 16].
After incubation for 20 h at 37 °C the invaded cells
were fixed and counted after cell staining with
hematoxilin-eosin. The assays were performed in tripli-
cates, six fields were counted per transwell filter and
the invasion index was calculated according to the
manufacturerer’s protocol.Real-time migration assay
The kinetics of cell migration was assayed using the
xCELLigence Real-Time Cell Analyzer (RTCA DP;
Roche). CIM-plate 16 wells used and 10,000cells were
plated in each well using serum-free DMEM. The lower
medium chamber contained DMEM with 10 % FCS.
Cells were allowed to settle for 30 min at room
temperature before being placed in the RTCA DP in a
humidified incubator at 37 °C with 5 % CO2. Data were
recorded every 15 min for 24 h. Plotted curves represent
the averages from three independent measurements.
Fig. 1 (See legend on next page.)
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Fig. 1 Expression of CK1 - isoforms during melanoma progression. a Relative mRNA expression (SYBR green real-time PCR) of three CK1 isoforms
in melanocytic cells, namely normal human melanocytes (NHM), cell lines derived from primary radial growth phase (RGP) plus vertical growth
phase melanoma (VGP) and cell lines from metastatic melanoma (MM). Normalized data (to ACTINB) are presented as scatter plot (mean with
SEM). Kuskal-Wallis statistics with Dunn’s multiple comparison was used to test for significant differences (* p < 0.05; ** p < 0.01). b CK1α, δ and ε
protein expression was determined by western blot analyses. Semi-quantification (ratios CK1/β-actin) are shown as scatter plots. Kuskal-Wallis
statistics with Dunn’s multiple comparison was used to test for significant differences (* p < 0.05; ** p < 0.01). c Relative mRNA expression of three
CK1- isoforms of patient-derived tissue samples. The analysis of CK-1 isoform expression was performed using benign melanocytic nevi (n = 4),
primary malignant melanomas (n = 9), and metastatic melanoma (n = 13) by quantitative real-time PCR. Normalized data are presented as scatter
plot (mean with SEM) and Kuskal-Wallis statistics with Dunn’s multiple comparison was used to test for significant differences (* p < 0.05; ** p < 0.01).
d CK1α (blue), δ (green) and ε (red) expression in tissue sections of benign nevi (n = 11), primary melanomas (n = 11) or melanoma metastases (n = 16)
was determined by immunofluorescence staining followed by confocal analysis. Kuskal-Wallis statistics with Dunn’s multiple comparison was used to
test for significant differences (* p < 0.05; ** p < 0.01)
Sinnberg et al. BMC Cancer  (2016) 16:594 Page 6 of 15Results
Expression levels of the CK1- isoforms α, δ and ε are
downregulated in metastatic melanoma cells in vivo
We analyzed expression of the CK1- isoforms α, δ and ε
on RNA and protein level in normal human melanocytes
(NHM) and melanoma cell lines representing the differ-
ent progression stages in melanoma from radial growth
phase (RGP), vertical growth phase (VGP) and meta-
static melanoma (MM) (Fig. 1a-c). We found a consist-
ent downregulation of CK1α expression on RNA and
protein level in RGP, VGP and metastatic melanoma cell
lines compared to NHMs. NHMs expressed significantly
more CK1δ RNA compared to the melanoma cell lines.
However, CK1δ protein expression was variable without
significant differences in the analyzed melanoma cell
lines. CK1ε expression was low in all cell lines analyzed
and could not be detected in NHMs on protein level
(Fig. 1a-c). CK1 γ1, γ2 and γ3 RNA expression was al-
most not detectable in the cell lines analyzed (Additional
file 1: Figure S1A). Therefore, we focused in the follow-
ing experiments on the CK1 isoforms α, δ and ε.
Next, we analyzed RNA and protein expression of the
CK1 isoforms α, δ and ε in vivo in tissue samples of be-
nign nevi, primary melanomas and metastatic melano-
mas using real-time PCR and immunofluorescence
analyses, respectively. RNA expression of all three CK1
isoforms did not differ significantly in the different tissue
types (Fig. 1c). By trend, CK1α RNA levels were reduced
in preparations of metastatic melanoma. In contrast, on
protein level we found a significant downregulation of
all three CK1- isoforms in metastatic melanomas com-
pared to primary melanoma cells (Fig. 1d). In summary,
we found in melanoma cell lines in vitro and in melan-
oma cells in vivo a consistent downregulation of CK1α
RNA and protein expression in metastatic melanoma
cells. Furthermore, we detected a downregulation of
CK1δ and ε protein expression in metastatic melanoma
cells in vivo compared to primary melanoma cells. This
did not correlate with RNA expression and with the ex-
pression levels of melanoma cells in vitro.CK1 δ and ε expression is partially reciprocally regulated
by a posttranscriptional mechanism in melanoma cells
So far it remains unknown whether the individual CK1
isoforms can regulate expression of the other isoforms
in melanoma cells. Therefore, we downregulated expres-
sion of the CK1 isoforms α, δ or ε in the two human
melanoma cell lines SbCl2 and SKMEL19 using isoform-
specific siRNAs and analyzed RNA and protein expres-
sion of all three CK1 isoforms. As shown in Fig. 2a,
downregulation of CK1α or CK1δ did not affect protein
expression of the other isoforms in both cell lines. How-
ever, downregulation of CK1ε expression induced CK1δ
expression most strongly in SKMEL19 cells (Fig. 2a).
Combined inhibition of CK1α and CK1δ did only
slightly affect CK1ε protein expression in SKMEL19
cells. However, downregulation of CK1α and CK1ε in-
creased CK1δ protein expression, again most strongly in
SKMEL19 cells. Downregulation of CK1δ and CK1ε had
no effect on CK1α expression. These data suggest that
CK1δ and ε regulate each other in a compensatory way
and the expression is not or only mildly influenced by
CK1α, whereas CK1α expression is independently regu-
lated from CK1δ and ε.
To analyze whether overexpression of the specific iso-
forms resulted in similar effects we upregulated specifically
CK1α expression by adenoviral gene transfer as previously
reported [9] and CK1δ and CK1ε by a doxycycline-
inducible lentiviral system in the two human melanoma cell
lines SbCl2 and SKMEL19 (Fig. 2b). Overexpression of
CK1α diminished only expression levels of CK1ε in SbCl2
and only at the highest induced expression level of CK1α.
Induction of CK1δ reduced CK1ε protein levels in
SKMel19 cells whereas elevated CK1ε levels were associ-
ated with lower CK1δ protein expression in SbCl2 cells
(Fig. 2b). CK1α expression was not significantly affected by
upregulation of the other CK1- isoforms. These data indi-
cate that the δ and ε isoforms negatively regulate expression
of each other. Analysis of RNA expression of the individual
CK1 isoforms after induction of gene expression using real-
time PCR indicated that overexpression of CK1α, CK1δ or
Fig. 2 CK1δ and ε reciprocally regulate their expression by a post-transcriptional mechanism. a Specific siRNA mediated knockdown of CK1- iso-
forms in SbCl2 (left panel) and SKMEL19 (right panel) melanoma cells. The influence of the corresponding isoforms on the other two isoforms
was evaluated by western blotting 48 h post siRNA transfection. Beta-actin detection served as a loading control. b Overexpression of CK1α, δ
and ε in SbCl2 and SKMEL19 melanoma cells by viral transduction. Lysates were prepared 48 h after overexpression and western blots were
probed with isoform specific antibodies and β-actin as a loading control. c Relative mRNA expression analysis of the three CK1 isoforms α, δ and
ε after overexpression of the respective isoforms 48 h post induction/ transduction. 18S rRNA was used as reference gene. Ad5-LacZ transduced
cells served as control for CK1α overexpression. Non-induced (Dox -) cells were used as control for overexpression of CK1δ and ε. All values were
referenced to untreated SbCL2 and SKMEL19 control cells. Mutliple t-test was used to calculate statistically significant (* p < 0.05) expression differences
after overexpression
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other CK1- isoforms (Fig. 2c). In summary, our data show
that CK1δ and CK1ε negatively regulate expression of the
respective other CK1 isoforms on a post-transcriptional
level, whereas CK1α expression is not significantly affected
by the other CK1- isoforms in melanoma cells.Modulation of CK1δ and CK1ε expression does not
significantly influence melanoma cell viability and
proliferation
Next, we looked for the functional effects of modulation
of CK1- isoform specific gene expression on survival
and proliferation of melanoma cells. First, we knocked
Fig. 3 Modulation of CK1δ and CK1ε expression does not significantly influence melanoma cell viability and proliferation. a Inhibition of isoform
specific CK1- activity via siRNA mediated knockdown of CK1α, CK1δ and CK1ε. SbCl2 (left diagram) and SKMEL19 (right diagram) cells were used
and cell growth was monitored for 4 days using the MUH viability assay. Shown is the mean with SD of hexatuplicates. b Inhibition of CK1-
activity via different small molecules (upper left and right plus lower left diagram) with predominant efficacy for CK1δ and CK1ε. Dose response
curves using viability measurements (MUH assay) 72 h after treatment with the inhibitors are shown. Mean values with SD values of
hexatuplicates are shown. The fourth diagram (lower right) shows dose response curves of melanoma cell lines treated with the allosteric CK1α
activator pyrvinium at 72 h post start of treatment. c Effects of CK1 specific small molecules on 3D spheroid SKMel19 cultures. Spheroids were
treated with the indicated concentrations of small molecules for CK1- inhibition or CK1α activation for 4 days. Live-dead staining with calcein-AM
(1 μM) and propidium iodide (100 ng/ml) and size measurements are shown. Mean with SEM values of five spheroids are used. Multiple t-tests
against vehicle controls were used for statistical analysis (* p < 0.05). d Effect of overexpression of the isoforms CK1α, CK1δ and CK1ε in SbCL2
and SKMEL19 melanoma cells. Isoforms were overexpressed as previously (Fig. 2b, c) and viability was assessed 72 h after overexpression of the
respective CK1- isoforms by MUH assays. Shown are changes in viability after overexpression as mean values with SD of hexatuplicates are shown
(*** p < 0.001)
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SKMEL19 melanoma cells using specific siRNAs
(Fig. 2a). Ninety-six hours after transfection we analyzed
survival and proliferation of the cells (Fig. 3a, Additional
file 2: Figure S2A). In both cell lines the downregulation
of CK1δ or CK1ε expression alone had no significant ef-
fect on cell growth or cell cycle. However, downregula-
tion of CK1α expression retarded cell growth and
increased the number of cell in the G1 phase of the cell
cycle in SbCl2 melanoma cells, but not in SKMEL19
cells (Fig. 3a, Additional file 2: Figure S2A, B) confirm-
ing our previous study [9]. To further ascertain the effect
of reduced CK1 activity on melanoma cell survival and
proliferation we treated five different human melanoma
cell lines with increasing doses of the CK1δ/CK1ε dom-
inant inhibitors D4476 [19], PF670462 [20] or IC261
[21] and measured cell viability 72 h after treatment. As
shown in Fig. 3b all three inhibitors did not significantly
reduce melanoma cell viability. In a 3D spheroid culture
model using collagen-embedded SKMEL19 spheroids
similar results were obtained (Fig. 3c). At the highest
concentration of IC261 a reduction in the size of the
spheroids was observed which, however, was not accom-
panied with cell death induction (Fig. 3c). Only treat-
ment of the cells with the CK1α activator pyrvinium
resulted in propidium iodide positive dead cells (Fig. 3c).
Also, overexpression of CK1δ or CK1ε in SbCl2 or
SKMEL19 melanoma cells did not change melanoma cell
viability and cell cycle (Fig. 3d, Additional file 2: Figure
S2C). In contrast, activation of CK1α by pyrvinium [22]
(Fig. 3b, c) or overexpression of CK1α in SbCl2 or
SKMel19 melanoma cells (Fig. 3d) significantly reduced
melanoma cell viability and induced apoptosis (Figs. 3b-
d, Additional file 2: Figure S2C). These data indicate that
CK1δ and CK1ε are not essential for melanoma cell sur-
vival and proliferation, whereas overexpression of CK1α
reduces viability of melanoma cells. This suggests that
CK1α is the most important CK1 isoform in melanoma
cells with a non-redundant function in tumorigenesis.
CK1α but not CK1δ and ε functionally affects melanoma
cell migration and invasion
In order to evaluate a further putative function of the
CK1 isoforms in tumorigenesis - an increase in the
migratory behavior of the tumor cells - we induced
the expression of CK1α, δ and ε isoforms in
SKMEL19 melanoma cells by doxycycline treatment
and measured the migratory potential of the cells
over time using the XCelligence system. Overexpres-
sion of CK1δ or ε in the melanoma cells led to no
difference in the migratory behavior compared to the
non-induced cells (Fig. 4a). However, overexpression
of CK1α significantly decreased migration of the mel-
anoma cells. 3D spheroid assays confirmed the resultsrevealing no influence of the CK1- isoforms δ and ε
on melanoma cell invasion of SKMEL19 cells into a
collagen I matrix (Fig. 4b). CK1α overexpression sig-
nificantly reduced the invasive growth within the
monitored 4 days and again induced cell death. To
further evaluate the effect of the CK1- isoforms on
the invasive potential of melanoma cells we used an
organotypic skin reconstruct using SbCL2 cells with
siRNA mediated knockdown of the three CK1- iso-
forms which were seeded together with primary hu-
man keratinocytes as an epidermal layer. Since SbCL2
cells originate from an RGP melanoma they do not
have the capacity to invade deep into the dermal part
by breaking through the basal membrane which sepa-
rates epidermal from dermal parts. Knockdown of
CK1α resulted in a pro-invasive phenotype indicated
by dermally invading melanoma cell nests as we
showed before [9]. Knockdown of the other two CK1-
isoforms δ or ε had no detectable effects on the
growth characteristics in the skin reconstruct model
(Fig. 4c). Our data indicate that CK1δ and ε do not
affect survival and migration/invasion of melanoma
cells in contrast to CK1α which seems to be the
dominant active CK1- isoform in melanoma cells.
CK1α, δ and ε differentially influence beta-catenin and
p53/p21 signaling in melanoma cells
It is known that β-catenin is a substrate of CK1α, δ and
ε [3]. Whereas phosphorylation of β-catenin at Ser45 by
CK1α results in degradation of β-catenin, CK1 δ/ε are
involved in the activation of the Wnt/β-catenin pathway
by the phosphorylation of dishevelled (Dvl). We ana-
lyzed whether overexpression of the individual CK1- iso-
forms as described above affects expression and activity
of β-catenin signaling. Interestingly, β-catenin total pro-
tein levels did not change 1–2 days after CK1- isoform
specific overexpression (Fig. 5a). However, as expected
phosphorylation of Ser45 of β-catenin was increased
after overexpression of CK1α (Additional file 3: Figure
S3A) and this directly correlated with the influence of
CK1α levels on the capacity to phosphorylate Ser45 in
melanoma cells in a kinase assay (Fig. 5b). Overexpres-
sion of CK1α in SKMEL19 enhanced the kinase activity
causing Ser45 phosphorylation, whereas the respective
knockdown in SbCl2 decreased this activity. The other
CK1- isoforms δ and ε did not show significant impact
on the phosphorylation of Ser45 of β-catenin (Fig. 5b).
In order to measure the general effect of CK1- iso-
forms on the canonical Wnt-signaling pathway we used
a firefly reporter system (Super8xTOPFlash) and tested
the luciferase activity in lysates of SKMEL19 cells after
induction of CK1- isoform specific overexpression. As
expected, CK1α overexpression decreased the endogen-
ous signaling activity, whereas CK1δ and ε enhanced the
Fig. 4 (See legend on next page.)
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Fig. 4 Functional effects of the modulation of CK1α, δ or ε on melanoma cell migration and invasion. a Real-time migration (upper panel) assays
using the XCelligence DP analyzer. SKMEL19 Tet-On cells were induced to overexpress CK1- isoforms (red symbols) by doxycylcline pre-treatment
for 48 h before seeding into the DP plates. Non-induced cells without doxycycline were used as reference controls (black symbols). For efficient
overexpression of CK1α (red symbols) the adenoviral overexpression system was used 16 h before seeding the cells into the DP plates and
effects were measured against lacZ control-transduced cells (black symbols). Shown are the cell indices of the measured impedance signals
over 48 h. b SKMEL19 melanoma spheroid assay after CK1 overexpression (starting 24 h before collagen type I embedding). Spheroid
spreading into the collagen matrix was microscopically monitored daily up to 4 days to estimate the invasive potential by referencing to
day 0. Five spheroids were used for the calculations (Mean with SD; * p < 0.05). c Organotypic skin reconstructs with CK1 knockdown in SbCL2 melanoma
cells. H&E staining is shown to reveal the invasive capacity into the dermal part after knockdown of CK1α. Matrigel coated invasion assays quantitatively
show the invasive capacity of SbCl2 melanoma cells after knockdown of CK1 (lower right diagram)
Sinnberg et al. BMC Cancer  (2016) 16:594 Page 11 of 15canonical Wnt signaling (Fig. 5c). Doxycycline treatment
alone as a negative control moderately induced the re-
porter, however to a much lesser extent as with CK1δ or
ε overexpression. These results confirm an inhibitory ef-
fect on Wnt/β-catenin signaling of CK1α and an activat-
ing effect of CK1 δ/ε in melanoma cells.
In addition, CK1α, δ and ε are known to influence ac-
tivity of p53 signaling by specific phosphorylation. Over-
expression of CK1δ and ε increased the protein levels of
p53 and its target p21 in SbCl2 and SKMEL19 melan-
oma cells. In contrast, overexpression of CK1α did not
influence p53 and p21 expression in this analysis
(Fig. 5a). This indicates that p53 signaling is predomin-
antly activated by CK1 δ/ε and not by CK1α in melan-
oma cells. However, knockdown of CK1α increased p21
expression (Additional file 3: Figure S3B). This goes in
line with previous findings that MDM2 is a target of
CK1α and CK1 δ/ε can phosphorylate p53 at N-terminal
activating phosphor-sites [23].
Discussion
Isoforms of the CK1 family have been shown to phos-
phorylate key regulatory molecules involved in cell cycle,
transcription and translation, the structure of the cyto-
skeleton, cell-cell adhesion and in receptor-coupled sig-
nal transduction. Although they share highly conserved
kinase domains, they differ significantly in the non-
catalytic domains, suggesting that each isoform may play
a specific role in regulating biological processes [3, 4].
CK1 family members share a substrate sequence consen-
sus in which position n-3 is necessarily occupied by an
acidic group or a phosphor-amino acid. This consensus
is D/E X X S/T for unprimed substrates or S/T-PO4 X
X S/T for primed targets. However also non-consensus
substrates exist like β-catenin and NFAT-4 hinting at
putative CK1- isoform specific functions [3, 4]. The
expression as well as the functional relevance of each
CK1- isoform in tumor cells and a possible functional
redundancy have not been comparatively analyzes so far.
We describe for the first time the expression of the
dominantly expressed CK1- isoforms α, δ and ε in mel-
anoma cells and their functional relevance in melanoma
progression. We provide strong evidence for a non-redundant and dominant role of CK1α compared to the
other CK1 isoforms in tumorigenesis supporting our
previous hypotheses [9]. We show that CK1α domin-
antly influences proliferation, invasion and progression
of melanoma cells, whereas CK1δ and CK1ε do not sig-
nificantly influence melanoma cell survival, proliferation,
migration and invasion in vitro. This was unexpected
since all three CK1- isoforms have been described to
play key roles in cell proliferation and in the control of
signaling pathways known to be important in tumor
cells.
CK1α can be found at the centrosomes, microtubule
asters and the kinetochore [3, 4, 24] and plays a role in
the mitotic spindle formation during cell division and in
DNA repair mechanisms as well as in RNA metabolism
[25, 26]. CK1δ is also involved in regulating cell cycle pro-
gression. It interacts with the spindle apparatus and regu-
lates phosphorylation of α-, β- and γ − tubulin [27–29]. In
addition, it was shown that checkpoint kinase 1 (Chk1) is
able to interact and specifically phosphorylate CK1δ and
by this regulate the kinase activity [30]. Furthermore,
inactivating mutations in CK1δ are able to impair SV40-
induced cellular transformation in vitro and mouse
mammary carcinogenesis in vivo [31] strengthening the
important function of CK1δ in cell proliferation. CK1ε is
able to interact with mitochondrial proteins in ovarian
cancer cells and by this increase growth and survival of
the tumor cells [32]. Furthermore, in breast cancer cells
CK1ε is a key regulator of cell proliferation by modulating
protein synthesis. CK1ε is able to phosphorylate the trans-
lation factor 4E-BP1, thereby regulating cap-dependent
translation [33]. In addition, fibrosarcomas seem to de-
pend on CK1ε and knocking down other isoforms of CK1
was not effective at inducing growth arrest in these cells
[34]. However, one study shows that re-expression of
CK1α in a lung cancer cell line in which the expression of
CK1α is also low causes reduced cell proliferation in vitro
and tumor growth in vivo [35]. Another study shows that
a pharmacological increase of CK1α protein significantly
diminished melanoma cell migration [36]. Furthermore, it
was shown that activation of CK1α by pyrvinium inhibits
the proliferation of colon carcinoma cells through inhib-
ition of the Wnt / beta-catenin signaling pathway [22].
Fig. 5 CK1α, δ and ε differentially influence beta-catenin and p53/p21 signaling in melanoma cells. a Western blotting of lysates from SbCl2 and
SKMEL19 melanoma cells 48 h after overexpression of CK1- isoforms to detect the CK1- substrates β-catenin and p53 with its downstream target
p21. b SbCL2 cells and SKMEL19 cells were used in a kinase assay using a peptidic β-catenin substrate (Ser45 phosphor-site) for
quantitative determination of Ser45-specific kinase activity of the different isoforms. SKMEL19 cells overexpressing CK1 isoforms and
SbCl2 cells transduced with siRNA 48 h before were lysed and subjected to a K-LISA CK1 assay using untreated cell lysates as
reference. Biological triplicates were used in case of SKMEL19 samples and quadruplicates in case of SbCL2 cells to calculate the mean
with SD (* p < 0.05). c Super8xTOPFlash reporter plasmid was transfected into SKMEL19 cells overexpressing CK1- isoforms and
luciferase activity was measured in hexatuplicates for estimation of the TCF/LEF mediated and β-catenin dependent transcriptional
activity. Luciferase activity was normalized to cell viability (* p < 0.05; ** p < 0.01)
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cell cycle regulation and progression in different tumor
types CK1δ and ε seems to be functionally redundant in
melanoma cells since we find no functional effect on cellcycle or tumor progression after modulation of their ex-
pression level in melanoma cells. In contrast, overex-
pression of CK1α induces cell cycle arrest and apoptosis
in metastatic melanoma cells and inhibits migration and
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growth phase melanoma cells induces invasive tumor
growth with a slightly reduced proliferation rate con-
firming our previous results [9]. This implies that each
CK1- isoform seems to have a unique function in pro-
moting the integrity and proliferation of specific types of
tumor cells.
In various cancer types CK1- isoforms are overexpressed.
Especially the CK1δ and CK1ε isoforms are overexpressed
in most tumor types compared to the respective benign tis-
sues [4]. However, we found that during melanoma pro-
gression protein expression of the CK1- isoforms α, δ and ε
is downregulated. This was consistently seen for CK1α
in vitro and in vivo, whereas expression of the CK1 δ and ε
isoforms are more heterogeneous as the in vitro and in vivo
expression data are not consistent.
It was reported that CK1ε enhances the β-catenin-
dependent proliferation in breast cancer [37] and a point
mutation in CK1δ promotes the emergence of colorectal
adenomas [38]. In contrast, a down-regulation of CK1δ and
ε-isoforms in a variety of tumor cell lines of different origin
induced cell cycle arrest and apoptosis. These effects are
also Wnt/β-catenin-independent, but dependent of acti-
vated RAS and inactive p53 [4, 39, 40]. Furthermore, it was
shown that impaired CK1δ activity attenuates SV40-
induced cellular transformation in vitro and mouse mam-
mary carcinogenesis in vivo [31]. We clearly show now in
this study that in the different melanoma cell models these
CK1- isoforms have no role in cell cycle progression and
migratory and invasive melanoma growth. However, over-
expression of CK1δ or CK1ε resulted in higher activity of
the Wnt/β-catenin signaling pathway and an increased p53
activity, whereas CK1α overexpression inhibited Wnt/β-ca-
tenin signaling and p53 activity. However, the suppressive
effect on p53 activity seems to depend on a gene dosage ef-
fect of CK1α. Furthermore we showed that in metastatic
melanoma cells CK1α is downregulated resulting in higher
transcriptional activity of the Wnt/beta-catenin signaling
pathway confirming our previous study pointing out that
CK1α is a tumor suppressor in melanoma cells [9]. It seems
that depending on the molecular background and oncogene
addictions in the tumor cells different CK1 isoforms have
dominant roles in the respective tumor types.
It is known that the CK1- isoforms CK1α, CK1δ and
CK1ε are capable to N-terminally phosphorylate the
tumor suppressor protein p53 in vitro and in vivo. This
leads to a reduced interaction of p53 with MDM2 and
thus to a stabilization and activation of p53 [3, 4]. How-
ever, phosphorylation of MDM2 by CK1α, CK1δ and
CK1ε can also promote p53 binding and degradation.
Furthermore, CK1δ is known to phosphorylate MDM2
on other sites, which prevents the degradation of p53
[41]. In addition it could be shown that after genotoxic
stress it comes to a transcriptional activation of CK1δ byp53 pointing out to an autoregulatory loop between
these two proteins [3, 4]. Therefore, the outcome of
CK1-kinase activation on p53 signaling has to be care-
fully analyzed in each tumor model.
The p53 signaling pathway seems to play a pivotal role
in regulating CK1α activity. Our first description of inva-
sive tumor growth due to knockdown of CK1α was sub-
stantiated by an ensuing work, which demonstrated the
rapid invasive growth of transformed cells in the small in-
testine of mice when p53 is inactivated together with
CK1α [42]. This suggests that loss of p53 in combination
with loss of CK1α activity favors invasive tumor growth.
Interestingly, p53 is a substrate of CK1α. Knockdown of
CK1α induces p53 transcriptional activity by reducing the
inhibitory effect of the MDM2 homologue MDMX for
p53 [43]. It was further shown that CK1α plays a central
role in mediating MDM2 control of p53 [11]. CK1α stim-
ulates p53 under stress conditions probably by direct
phosphorylation of p53 [10, 40]. Thereby, CK1α could be
a cellular fine-tuning tool for the regulation of p53 activity,
which is dependent on the gene dosage.
Conclusions
We show that CK1α has a non-redundant and dominant
role in melanoma progression. It has still to be deter-
mined which functional role the CK1δ and ε isoforms
have in melanoma cells independent of cell cycle pro-
gression and migration/invasion. The ability of the
CK1- isoforms to regulate several important signaling
molecules modulated in different types of tumors point
out that they might be suitable targets for clinical inter-
vention also in melanoma therapy.
Additional files
Additional file 1: Figure S1. Expression of CK1γ isoforms in melanoma.
(A) Relative mRNA expression of the γ1, γ2 and γ3 CK1 isoforms in
melanocytic cells namely normal human melanocytes (NHM), cell lines
derived from primary radial growth phase (RGP) plus vertical growth
phase melanoma (VGP) and cell lines from metastatic melanoma (MM).
The analysis of CK1 isoform expression was performed by quantitative
SYBR green real-time PCR. Data were normalized to β-actin (ACTINB) and
presented as scatter plot (mean with SEM). (B) Relative mRNA expression
of the γ1, γ2 and γ3 CK1- isoforms of patient-derived tissue samples. The
analysis of CK-1 isoform expression was performed using benign melanocytic
nevi (n= 4), primary malignant melanomas (n= 9), and metastatic melanoma
(n= 13) by quantitative real-time PCR. Data were normalized to β-actin
(ACTINB). Data are presented as scatter plot (mean with SEM). (TIF 600 kb)
Additional file 2: Figure S2. Influence of the modulation of CK1
isoform expression on cell viability and cell cycle. (A) Inhibition of isoform
specific CK1-activity via combined siRNA mediated knockdown of CK1α,
CK1δ and CK1ε. SbCl2 (left diagram) and SKMEL19 (right diagram) cells
were transduced with isoform specific siRNA or a non-silencing control
and cell growth was monitored for 4 days using the MUH viability assay.
Fluorescence intensities were normalized (100 %) to the start point at
24 h post transfection of the siRNA. Shown is the mean with SD of
hexatuplicates. (B) Cell cycle analysis after knockdown of CK1 isoforms in
SbCl2 and SKMel19 melanoma cells. After ice-cold ethanol fixation
melanoma tumor cells were stained with 50 μg/ml propidium iodide
Sinnberg et al. BMC Cancer  (2016) 16:594 Page 14 of 15containing RNase in PBS for 30 min and analyzed in a LSRII flow cytometer
(BD). (C) Cell cycle analysis at 48 h after induction of CK1 isoforms revealed a
significant subG1 apoptotic population only after overexpression of CK1α.
(TIF 701 kb)
Additional file 3: Figure S3. Effect of the modulation of CK1α
expression on p53 and β-catenin signaling. (A) Western blot of lysates
from SKMel19 cells at 48 h post adenoviral overexpression of CK1α for
the detection of CK1 isoforms, S45-phosphorylated β-catenin and p53/
p21. (B) Western blots for the p53 target p21 of lysates from SbCl2
and SKMEL19 cells at 48 h post transfection with CK1 specific siRNAs.
(TIF 2129 kb)
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